expert perspectives

in Multiple Sclerosis

Expert Perspectives in Multiple Sclerosis to Cover Key Topics in Multiple Sclerosis Treatment


Expert Perspectives delivers health care providers with insights from key thought leaders on the latest advancements and current practices in medicine, in a concise and timely format. This issue of Expert Perspectives in Multiple Sclerosis will feature selected topics in Multiple Sclerosis that we hope you will find of value in your clinical practice.

The clinicians who were surveyed selected the following experts and topics.

Community-Selected Experts: 

Robert A. Bermel, MD, MBA

Staff Neurologist
Mellen Center for Multiple Sclerosis
Cleveland Clinic
Cleveland, OH

Malcolm H. Gottesman, MD

Chief Emeritus, Division of Neurology
Winthrop Comprehensive MS Care Center, NYU Langone Hospital
Professor, Department of Neurology
NYU Long Island School of Medicine
Mineola, NY

Eric C. Klawiter, MD, MSc

Associate Neurologist
Massachusetts General Hospital
Associate Professor of Neurology
Harvard Medical School
Boston, MA

Community-Selected Topics: 

Expert Roundtables

    Emerging Therapies for Multiple Sclerosis
    Multiple Sclerosis: Safety Profiles of Disease-Modifying Therapies
    Recent Advances in Multiple Sclerosis
    Clinical Trials and Basic Science Advancements in Multiple Sclerosis

Clinical Topic Updates 

    Sphingosine-1-Phosphate Receptor Modulators for the Treatment of Multiple Sclerosis
    Real-World Effectiveness of First-line Treatment in Relapsing-Remitting Multiple Sclerosis
    Imaging and Nonimaging Biomarkers in Multiple Sclerosis
    Newer Disease-Modifying Therapies for Relapsing Forms of Multiple Sclerosis

Patient Care Perspectives 

    Women With Multiple Sclerosis and the Potential Impacts of Menopause
    Detection and Monitoring of Multiple Sclerosis: Past, Present, and Future
    Quality-of-Life Determinants in Multiple Sclerosis: Pearls From Practice
    Elderly Patients With Multiple Sclerosis: Efficacy of Disease-Modifying Therapy 

More in Multiple Sclerosis


Multiple Sclerosis

Questions Surrounding Early Use of Ocrelizumab in Patients With Relapsing Multiple Sclerosis

Clinical Study Insights by David A. Hafler, MD

What we have learned from rheumatoid arthritis, where we can see the initial event, is that if you go in hard with the biological anti–tumor necros...READ MORE


Multiple Sclerosis

Disease-Modifying Therapies for Relapsing Multiple Sclerosis

Patient Care Perspectives by Dean Wingerchuk, MD, FRCP(C)

For over 10 years, the most common treatment practice for patients with multiple sclerosis (MS) has been what is referred to as an escalation appro...READ MORE


Multiple Sclerosis

Comorbidities in Multiple Sclerosis and Impact on Diagnosis and Management

Clinical Topic Updates by Patricia K. Coyle, MD, FAAN, FANA

Emerging data link a range of comorbidities in multiple sclerosis (MS) to diagnostic delays, disability progression, health-related quality of life...READ MORE

More In Neurology

Tuberous Sclerosis Complex

Role Of Mammalian Target Of Rapamycin Inhibitors In The Treatment Of Tuberous Sclerosis Complex–Associated Epilepsy

Expert Roundtables by David N. Franz, MD; Gary W. Mathern, MD; and Elizabeth A. Thiele, MD, PhD

Tuberous Sclerosis Complex

Epilepsy Management In Tuberous Sclerosis Complex: Evolving Treatment Approaches

Expert Roundtables by David N. Franz, MD; Gary W. Mathern, MD; and Elizabeth A. Thiele, MD, PhD

Tuberous Sclerosis Complex

Tuberous Sclerosis Complex: Neurologic/Neuropsychiatric Impacts, Morbidity, And Mortality

Clinical Topic Updates by Elizabeth A. Thiele, MD, PhD